| Company Name: |
Alfa Chemistry |
| Tel: |
+1-5166625404; |
| Email: |
Info@alfa-chemistry.com |
| Company Name: |
ChemOrigin Pharm |
| Tel: |
15026428026 19002516454 |
| Email: |
ChemOrigin@126.com |
|
| | 2(1H)-Isoquinolinepropanenitrile, 5-[[4-[[4-(1,6-dihydro-1,4,5-trimethyl-6-oxo-3-pyridinyl)-2,6-dimethoxyphenyl]methyl]-1-piperazinyl]methyl]-3,4-dihydro-1-methyl-β-oxo-α-[[4-(trifluoromethyl)-2-thiazolyl]methylene]- Basic information |
| Product Name: | 2(1H)-Isoquinolinepropanenitrile, 5-[[4-[[4-(1,6-dihydro-1,4,5-trimethyl-6-oxo-3-pyridinyl)-2,6-dimethoxyphenyl]methyl]-1-piperazinyl]methyl]-3,4-dihydro-1-methyl-β-oxo-α-[[4-(trifluoromethyl)-2-thiazolyl]methylene]- | | Synonyms: | 2(1H)-Isoquinolinepropanenitrile, 5-[[4-[[4-(1,6-dihydro-1,4,5-trimethyl-6-oxo-3-pyridinyl)-2,6-dimethoxyphenyl]methyl]-1-piperazinyl]methyl]-3,4-dihydro-1-methyl-β-oxo-α-[[4-(trifluoromethyl)-2-thiazolyl]methylene]-;BRD9 Degrader-2;Amphista Therapeutics' BRD9 Degrader (Compound B11) | | CAS: | 3033018-68-4 | | MF: | C40H43F3N6O4S | | MW: | 760.87 | | EINECS: | | | Product Categories: | | | Mol File: | 3033018-68-4.mol | ![2(1H)-Isoquinolinepropanenitrile, 5-[[4-[[4-(1,6-dihydro-1,4,5-trimethyl-6-oxo-3-pyridinyl)-2,6-dimethoxyphenyl]methyl]-1-piperazinyl]methyl]-3,4-dihydro-1-methyl-β-oxo-α-[[4-(trifluoromethyl)-2-thiazolyl]methylene]- Structure](CAS/20240320/GIF/3033018-68-4.gif) |
| | 2(1H)-Isoquinolinepropanenitrile, 5-[[4-[[4-(1,6-dihydro-1,4,5-trimethyl-6-oxo-3-pyridinyl)-2,6-dimethoxyphenyl]methyl]-1-piperazinyl]methyl]-3,4-dihydro-1-methyl-β-oxo-α-[[4-(trifluoromethyl)-2-thiazolyl]methylene]- Chemical Properties |
| Boiling point | 856.3±75.0 °C(predicted) | | density | 1.297±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | | pka | 6.66±0.10(predicted) |
| | 2(1H)-Isoquinolinepropanenitrile, 5-[[4-[[4-(1,6-dihydro-1,4,5-trimethyl-6-oxo-3-pyridinyl)-2,6-dimethoxyphenyl]methyl]-1-piperazinyl]methyl]-3,4-dihydro-1-methyl-β-oxo-α-[[4-(trifluoromethyl)-2-thiazolyl]methylene]- Usage And Synthesis |
| Uses | BRD9 Degrader-2 (Compound B11) is a BRD9 degrader (DC50 ≤1.25 nM; Dmax≥75%). BRD9 Degrader-2 can be used for research of cancers[1]. | | IC 50 | BRD9: <1.25 nM (DC50) | | References | [1] David MCGARRY, et al. Compounds for targeted protein degradation. Patent. WO2024057021A1 |
| | 2(1H)-Isoquinolinepropanenitrile, 5-[[4-[[4-(1,6-dihydro-1,4,5-trimethyl-6-oxo-3-pyridinyl)-2,6-dimethoxyphenyl]methyl]-1-piperazinyl]methyl]-3,4-dihydro-1-methyl-β-oxo-α-[[4-(trifluoromethyl)-2-thiazolyl]methylene]- Preparation Products And Raw materials |
|
|
Tag:2(1H)-Isoquinolinepropanenitrile, 5-[[4-[[4-(1,6-dihydro-1,4,5-trimethyl-6-oxo-3-pyridinyl)-2,6-dimethoxyphenyl]methyl]-1-piperazinyl]methyl]-3,4-dihydro-1-methyl-β-oxo-α-[[4-(trifluoromethyl)-2-thiazolyl]methylene]-(3033018-68-4)
Related Product Information
|